Platelet-activating factor stimulates a rapid accumulation of inositol (1,4,5)trisphosphate in guinea pig eosinophils: Relationship to calcium mobilization and degranulation

The Journal of Allergy and Clinical Immunology

Volumn 88, Issue 1, 1991, Pages 114-124

  Kroegel, Claus ^a   Chilvers, Edwin R ^a   Giembycz, Mark A ^a   Challiss, R A John ^b   Barnes, Peter J ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

calcium mobilization; degranulation; Eosinophil; inositol (1 4 5)trisphosphate; platelet activating factor

Indexed keywords

APAFANT; CALCIUM; INOSITOL TRISPHOSPHATE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEGRANULATION; EOSINOPHIL; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; AZEPINES; CALCIUM; CELL SEPARATION; CYTOPLASMIC GRANULES; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; GUINEA PIGS; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; PERITONEAL CAVITY; PLATELET ACTIVATING FACTOR; SECOND MESSENGER SYSTEMS; STIMULATION, CHEMICAL; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TRIAZOLES;

EID: 0025835455     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(91)90308-B     Document Type: Article

References (44)

1. The eosinophil and the pathophysiology of asthma [Postgrad course]
2. Platelet-activating factor as a mediator of allergic disease
3. Perspectives in platelet-activating factor research
4. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells
5. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils
6. Effects of platelet-activating factor on the chemotaxis of normodense eosinophils from normal subjects
7. Skin eosinophilia in atopic patients
8. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration: modulation by prostacyclin, platelet depletion, and selective antagonists
9. 4 synthesis by purified human eosinophils
10. 2 and E-series prostaglandins
11. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils
12. Stimulation of degranulation from human eosinophils by platelet-activating factor
13. Evidence for two platelet-activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization, degranulation, and Superoxide anion generation in eosinophils
14. Activation and release of enzymes and major basic protein from guinea pig eosinophil granulocytes induced by different inflammatory stimuli and other substances
15. Density heterogeneity of eosinophils: induction of hypodense eosinophils by platelet-activating factor
16. Inositol trisphosphate and diacylglycerol: two interacting second messengers
17. 3H]WEB 2086
18. Characterization of platelet-activating factor-induced elevation of cytosolic-free calcium concentration in eosinophils
19. Receptor-mediated accumulation of D-myo inositol (1,4,5)trisphosphate mass in guinea pig eosinophils
20. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll)
21. Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization
22. 3H]inositol (1,4,5)trisphosphate binding sites in adrenal-cortical membranes: characterisation and validation of a radioreceptor assay
23. 3H]arachidonic acid and changes in cytosolic-free calcium in fura-2-loaded platelets by ionomycin and collagen
24. Pharmacological actions of WEB 2086, a new specific antagonist of platelet-activating factor
25. Non-oxidative antimicrobial reactions of leucocytes
26. 4 stimulation of phagocytes results in the formation of inositol 1,4,5-trisphosphate
27. Quantitative changes in inositol 1,4,5-trisphosphate in chemoattractant-stimulated neutrophils
28. Secretagogue-induced phosphoinositide metabolism in human leukocytes
29. Pertussis toxin inhibits peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells
30. 2+ levels
31. The eosinophil
32. Inositol 1,4,5-trisphosphate and inositol 1,2-cyclic 4,5-trisphosphate are minor components of total mass of inositol trisphosphate in thrombin-stimulated platelets
33. 2+ mobilization in the apparent absence of inositol 1,3,4-trisphosphate 3-kinase activity
34. Chemotactic peptide activation of human neutrophils and HL-60 cells
35. 32P]inositol 1,4,5-trisphosphate in hepatocytes and neutrophils
36. Inositol trisphosphate, a novel second messenger in cellular signal transduction
37. Inositol phosphates: synthesis and degradation
38. Formation and metabolism of inositol 1,3,4,5-tetrakisphosphate in liver
39. The inositol tris/tetrakisphosphate pathway—demonstration of inositol 1,4,5-trisphosphate 3-kinase activity in animal tissues
40. 2+, and insulin release in carbamoylcholine-stimulated RIN m5F cells
41. Stimulus-response coupling in human platelets: changes evoked by platelet-activating factor in cytosolic-free calcium monitored with fluorescent calcium indicator quin-2
42. Chemotactic peptide receptor modulation in polymorphonuclear leukocytes
43. Contraction of guinea pig ileal smooth muscle by acetyl glycerol ether phosphorylcholine